过敏原特异性免疫治疗(AIT)
Search documents
过敏原检测和药品销量大增,春季花粉过敏高发该怎么用药?
Jie Mian Xin Wen· 2025-03-26 06:02
Core Insights - The article highlights a significant increase in allergy testing and medication sales due to the seasonal rise in pollen allergies, particularly in cities like Beijing [1][4][5] Group 1: Allergy Trends - March marks the peak of pollen allergies in many regions, with Beijing experiencing particularly high pollen levels [1][3] - Data from China Weather Network indicates that pollen concentrations in cities like Beijing and Guangzhou are at "very high" levels, prompting warnings for individuals prone to allergies [1][4] Group 2: Medication Demand - There has been a notable surge in the demand for allergy medications, with a reported 330% increase in related drug searches in Beijing since mid-March [4] - Sales data from 1药网 shows a 48% month-on-month increase in allergy medication sales in Beijing [5] - Popular allergy medications include Reyonacort, Fluticasone, and other nasal sprays, with some products seeing over 50% year-on-year sales growth [4][5] Group 3: Clinical Insights - The number of patients presenting with pollen allergies has increased, with various symptoms ranging from allergic rhinitis to asthma [5][6] - Medical professionals recommend preventive measures and appropriate medication usage to manage seasonal allergies effectively [6][7] Group 4: Treatment Options - Treatment strategies include physical protection measures and pharmacological interventions, such as nasal corticosteroids and antihistamines [6][7] - Allergen-specific immunotherapy (AIT) is suggested for patients with severe symptoms, with an effectiveness rate of around 80% [8]